Advinus Therapeutics Exhibiting at 18th China International Agrochemical & Crop Protection Exhibition held in Shanghai, China from 01st – 03rd Mar, 2017. Showcasing our service offerings to the Agro sector.
Advinus Therapeutics at India Medical Device 2017 (11th-13th February), at Bangalore International Convention and Exhibition Centre, Bengaluru. Showcasing our service offerings to the medical device sector.
Dr. K S Rao and Mr. Vidya Sagar Kalikivaya representing Advinus Therapeutics at Crops and Chemicals 2017 in Berlin! Advinus is a GLP, cGMP and AAALAC certified Contract Research Organization serving diverse sectors like Chemicals, Specialty Chemicals, Agro-Chemicals and Nutraceuticals. Advinus is renowned for developing registration packages for global regulatory submissions.
Dr. K. S Rao and Sushil Momaya from Advinus exhibited at the RBF 8th International Symposium, Advances in New Drug Discovery & Development ,from 2nd – 4th Feb at Ahmedabad.
The RBF Symposium, with its unique focus and format, has been creating an unparalleled knowledge-sharing platform for scientists across the globe. It was a great opportunity for Advinus to meet experts in the field.
Congratulations Advinus!!
Advinus was one of the only two preclinical partners who were felicitated by DRL. Thank you Dr. Reddy’s for this fruitful partnership!
The recognition is a reflection of Advinus’ commitment to quality, timelines and customer responsiveness.
We are pleased to announce Dr. KS Rao and Mr. Sushil Momaya from Advinus attended AgroChemEx (ACE) 2016, held in Shanghai from 16 to 18 October, 2016. ACE is an annual agrochemical symposium and exhibition, organised by the China Crop Protection Industry Association (CCPIA) since 2005. The event attracts over 600 exhibitors, specialising in technical, formulation and adjuvants, which together accounts for 80% of China’s pesticide output. Advinus met with many of the top agrochemical producers at ACE.
Dr. Swati Patel, Group Head, DMPK & CP – Biologics, and Mr. Sushil Momaya – Manager, Business Development represented Advinus at the 9th Biosimilars Congregation 2016 in Mumbai on the 22nd of September. Advinus has evaluated more than a dozen Biosimilars for Toxicology studies for Indian DCGI and global regulatory submissions. Our Biosimilar offerings include Toxicology, Toxicokinetics, Pharmacokinetics, Pharmacodynamics, Biomarker Analysis and Immunogenicity Assessment.
Ms. Priya S – DGM, Business Development, is representing Advinus Therapeutics at Specialty & Agro Chemicals America 2016 from September 7–9 in Charleston, South Carolina. Advinus is a leading GLP certified Contract Research Organisation providing services in Chemistry, Analytical R&D, DMPK and Safety Assessment for Agrochemical and Specialty Chemical markets. We would appreciate an opportunity to meet you to better understand your testing requirements.
Advinus representatives Priya S and Vidya Sagar from the Business Development Team at Pharma Chem Outsourcing in New Jersey. Advinus is a leading GLP certified Contract Research Organisation for Discovery Chemistry, Analytical Chemistry and Process Chemistry. Advinus also excels in Analytical R&D, DMPK and Safety Assessment.
Advinus offers heterotopic (subcutaneous) xenograft models in immuno-deficient mice. Xenograft models of human cancer play an important role in the screening and evaluation of candidates for new anticancer agents. These models are derived from human tumor cell lines. For more details visit: PD Efficacy Models Oncology.
A range of animal models of Fibrosis are on offer for screening anti-fibrotic activity. Advinus has experience in running multiple drug discovery programs from hit identification to clinical candidate identification in the area of fibrosis. Fibrosis is often defined as a wound-healing response that has gone out of control. For more details about services offered, please visit: PD Efficacy Models Other Therapeutic Areas.